Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 7/20 | 0.56 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.56 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.54 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.53 |
| ▸ | NMUR1 | Q9HB89 | 3/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30198135 | 0.92 | NTSR1 (0.55) | OPRD1NTSR1NTSR2NMUR2NMUR1 | |
| SCHEMBL30835500 | 0.91 | NTSR1 (0.55) | OPRD1NTSR1NTSR2NMUR2NMUR1 | |
| SCHEMBL31670643 | 0.84 | OPRD1 (0.59) | OPRD1NTSR1NTSR2OPRM1 | |
| SCHEMBL30198139 | 0.83 | NPY1R (0.55) | OPRD1NTSR1NTSR2OPRM1 | |
| SCHEMBL30633111 | 0.82 | NTSR1 (0.56) | OPRD1NTSR1NTSR2NMUR2NMUR1 | |
| SCHEMBL31461843 | 0.81 | OPRD1 (0.54) | OPRD1NTSR1OPRM1 | |
| SCHEMBL31462040 | 0.81 | CALCR (0.54) | OPRD1 | |
| SCHEMBL29510563 | 0.81 | NTSR2 (0.58) | NTSR1NTSR2 | |
| SCHEMBL30835501 | 0.81 | NTSR1 (0.54) | OPRD1NTSR1NTSR2OPRM1 | |
| SCHEMBL29467322 | 0.80 | OPRD1 (0.56) | OPRD1NTSR1NTSR2NMUR2NMUR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4362970-A1 | MONOMERIC FUSION PEPTIDES AND METHOD OF USE THEREOF | Allysta Pharmaceuticals, Inc. (US) | 2024-05-08 | — | — | EP | disclosed |
| CN-117750969-A | Monomeric fusion peptides and methods of use thereof | 雅利斯塔制药公司 | 2024-03-22 | — | — | CN | disclosed |
| US-20230021946-A1 | MONOMERIC FUSION PEPTIDES AND METHOD OF USE THEREOF | ALLYSTA PHARMACEUTICALS, INC. | 2023-01-26 | — | — | US | disclosed |